SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-37474 |   Medical Devices

Historical data: 2017 - 2023

Forecast period: 2025 - 2031

Quantitative units: Revenue in USD million and CAGR from 2025 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Sexually Transmitted Disease (STD) Diagnosis Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET

7.1 GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)

8.1 GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

8.2 GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

9.1 GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

9.2 GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

10.1 GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)

10.2 GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)

11.1 NORTH AMERICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

11.2 NORTH AMERICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

11.3 NORTH AMERICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

11.4 NORTH AMERICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

11.5 NORTH AMERICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

11.6 NORTH AMERICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

12.1 EUROPE SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

12.2 EUROPE SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

12.3 EUROPE SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

12.4 EUROPE SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

12.5 EUROPE SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

12.6 EUROPE SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

13.1 ASIA PACIFIC SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

13.2 ASIA PACIFIC SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

13.3 ASIA PACIFIC SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

13.4 ASIA PACIFIC SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

13.5 ASIA PACIFIC SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

13.6 ASIA PACIFIC SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

14.1 LATIN AMERICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>

14.2 LATIN AMERICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

14.3 LATIN AMERICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

14.4 LATIN AMERICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

14.5 LATIN AMERICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

14.6 LATIN AMERICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>

16.1 Abbott

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Roche

16.3 Thermo Fisher Scientific

16.4 Aposcience

16.5 BCR Diagnostics

16.6 BD Medical

16.7 Biocartis

16.8 BioM rieux

16.9 Bio-Rad

16.10 Cepheid

16.11 Danaher

16.12 DiaSorin

16.13 Quidel

16.14 GenMark Diagnostics

16.15 Hologic

16.16 OraSure Technologies

16.17 Qualigen

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

Market by Type :

Chlamydia testing
Syphilis testing
Gonorrhoea testing
Herpes simplex virus testing
Human papilloma virus testing
Human immunodeficiency virus testing

Market by Application :

Government organizations
Hospitals
Diagnostic clinics

Companies

Abbott
Roche
Thermo Fisher Scientific
Aposcience
BCR Diagnostics
BD Medical
Biocartis
BioM rieux
Bio-Rad
Cepheid
Danaher
DiaSorin
Quidel
GenMark Diagnostics
Hologic
OraSure Technologies
Qualigen

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.